Navigation Links
Arena and Eisai Complete End-of-Review Meeting with FDA for Lorcaserin New Drug Application
Date:12/22/2010

SAN DIEGO and WOODCLIFF LAKE, N.J., Dec. 22, 2010 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) and Eisai Inc. announced today the completion of an end-of-review meeting with the US Food and Drug Administration (FDA) for the lorcaserin New Drug Application (NDA).

"The meeting discussions reinforce our position that we have a path forward to seek FDA approval of lorcaserin," said Jack Lief, Arena's President and Chief Executive Officer. "Based on guidance we have received from the agency, we are executing several activities and expect to resubmit the lorcaserin NDA by the end of 2011. As we continue discussions with the FDA to refine elements of our plan, we may identify ways to shorten this timeline. We will provide more details about our plan on the conference call and webcast this morning."

Arena submitted an NDA for lorcaserin to the FDA in December 2009, and the FDA issued a Complete Response Letter (CRL) in October 2010. In the CRL, the FDA outlined non-clinical and clinical reasons for its decision and provided recommendations relating to addressing such issues. The end-of-review meeting with the FDA included a discussion of the FDA's position on issues identified in the CRL and Arena's plan to respond.

Conference Call & Webcast Arena will host a conference call and webcast today, December 22, 2010, at 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time) to discuss its plan to address the CRL and resubmit the lorcaserin NDA. The conference call may be accessed by dialing 877.643.7155 for domestic callers and 914.495.8552 for international callers. Please specify to the operator that you would like to join the "Lorcaserin" conference call. The conference call will be webcast live under the investor relations section of Arena's website at www.arenapharm.com, and will be archived there for 30 days fol
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Arena Pharmaceuticals to Host Conference Call and Webcast to Provide Update Following Lorcaserin End-of-Review Meeting With FDA
2. Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD811 for Pulmonary Arterial Hypertension
3. Arena Pharmaceuticals Announces Third Quarter 2010 Financial Results and Reviews Recent Developments
4. Arena Pharmaceuticals Provides Update on GPR119 Portfolio for Type 2 Diabetes
5. Endologix Announces Publication of Clinical Trial Results Supporting Anatomical Fixation with a Suprarenal Aortic Extension
6. Arena and Eisai Announce Upcoming Lorcaserin Presentations at Obesity 2010
7. Arena and Eisai Provide Update on Lorcaserin FDA Advisory Committee Meeting
8. Arena Pharmaceuticals to Host Conference Call and Webcast Following Lorcaserin FDA Advisory Committee Meeting
9. Arena Pharmaceuticals Submits New Drug Application to FDA for Lorcaserin for Weight Management
10. Published Data Demonstrate Arena Pharmaceuticals Lorcaserin Has Low Abuse Potential
11. Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... June 19, 2013 The Physician-Patient Alliance for Health ... The need to urgently address this issue has ... Event Alert #50 , "Medical device alarm safety in hospitals." ... January 2008 and June 2012, there were 98 alarm related ... death (82%) , 13 resulted in permanent loss of ...
(Date:6/19/2013)... June 19, 2013   BioCision , a ... and handling in many areas of medical and ... patents by the U.S. Patent Office that apply ... to standardize sample handling to ensure the consistency ... common laboratory procedures. Patent number ...
(Date:6/19/2013)... 19, 2013 ... DrugPatentWatch to its extensive list of ...      (Logo: http://photos.prnewswire.com/prnh/20130128/590935) , ... pharmaceutical, drug patents and their expirations. ... business functions of patent agents and ...
Breaking Medicine Technology:Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 2Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 3BioCision Announces Two New U.S. Patents for Thermo-Conductive Products that Standardize Sample Handling in Laboratory Research 2Drug Patent Watch 2Drug Patent Watch 3
(Date:6/19/2013)... Brain not working? Functional medicine pioneer Datis ... minor brain problems as brain fog, memory loss, fatigue, ... indicate the brain may be degenerating—or aging—too quickly, raising ... and other neurological diseases. Why Isn’t My Brain ... is now available online at Amazon and ...
(Date:6/19/2013)... Chrysler made news recently when it refused to accept ... The Jeep models in question are the 1993-2004 Jeep Grand ... NHTSA are vulnerable to fire and explosion in a crash. ... and have been alleged to catch fire or explode upon ... 32 rear-end crashes, which resulted in 44 deaths and the ...
(Date:6/19/2013)... 2013 Citi Bike has come to New York ... David Perna to know for sure how many patients will choose ... they’ll have the option. In fact, he’s happy about anything ... also make it more convenient for them to visit his office ... of Complimentary Alternative Medicine at Back and Body Medical and an ...
(Date:6/19/2013)... Lawrence, KS (PRWEB) June 19, 2013 ... photographs is common with today’s computer software, it creates ... a form of misconduct. As an already published case ... of photo manipulation. , The Journal of Parasitology ... image manipulation in a 2004 article published in ...
(Date:6/19/2013)... LOS ANGELES (June 19, 2013) In what is ... with the most common form of hereditary dystonia ... experts in deep brain stimulation report good success ... director of the Movement Disorders Program at Cedars-Sinai Medical ... chief of the Division of Neurosurgery at Beth Israel ...
Breaking Medicine News(10 mins):Health News:Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later 2Health News:Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later 3Health News:Zinda & Davis PLLC: Why the Chrysler Recall Refusal Matters And May Set a Dangerous Precedent 2Health News:Zinda & Davis PLLC: Why the Chrysler Recall Refusal Matters And May Set a Dangerous Precedent 3Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 2Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 3Health News:Altered Photo in Journal Article Illustrates the Need for Manipulation Guidelines 2Health News:Long-term study reports deep brain stimulation effective for most common hereditary dystonia 2
... Joint distraction (the use of a surgical frame around a ... in severe end stage osteoarthritis (OA) of the knee, as ... EULAR 2008, the Annual Congress of the European League Against ... external fixation frame, with springs, was used to bridge the ...
... Paris, France, Friday 13 June 2008: Tocilizumab plus ... safety in patients with moderate to severe rheumatoid ... anti-tumour necrosis factor (anti-TNF) therapy, according to a ... Annual Congress of the European League Against Rheumatism ...
... WASHINGTON, June 13 A new "hospital ... gives the Department,s,health care system high marks, with ... commonly accepted by the health,care industry., "This ... of care VA,provides to our veterans," said Dr. ...
... Life Urges Congress to Preserve ... Compassionate End-of-Life Care, WASHINGTON, June 13 ... Commission (MedPAC),reported that the rapid growth of the Medicare hospice benefit ... spending per,beneficiary. According to the report, "Evaluating Medicare,s Hospice,Benefit," much more ...
... scene affected years later, with those injured suffering most , , ... after the World Trade Center terrorist attacks, one in eight ... post-traumatic stress disorder (PTSD), a New York City Health Department ... Manhattan residents is three times the usual rate and matches ...
... of cardiovascular disease (CVD) for people with rheumatoid arthritis (RA) ... CVD in people with type 2 diabetes, according to the ... Annual Congress of the European League Against Rheumatism in Paris, ... 8.6% of the RA population studied, a figure that was ...
Cached Medicine News:Health News:Joint distraction promotes structural repair in patients with severe knee osteoarthritis 2Health News:30 percent RA patients refractory to anti-TNFs achieve disease remission with tocilizumab plus metho 2Health News:Health Care 'Report Card' Gives VA High Marks 2Health News:More Data Needed Before Changing Medicare Hospice Funding, Report Finds 2Health News:More Data Needed Before Changing Medicare Hospice Funding, Report Finds 3Health News:PTSD High Among Witnesses to 9/11 2Health News:Rheumatoid arthritis is a risk factor for cardiovascular disease 2
... of three test plates(6mm, 3mm, and 1.5mm thick), ... of 600 - 15 seconds. No special glasses ... detected if stereopsis is present. Test plates can ... patient learning the correct answer. Large stereo acuity ...
8 X 1 Red Filter. Color Filters are designed to filter out all other color regions of the visible spectrum except the specified color. Color Filters are excellent for contrast enhancement and color r...
Last 3-6 months average refrigeration will prolong life. Pupil gauge printed on penlight 4 1/2" long 1/2" around....
Doctors six-pack long lasting, disposable, diagnostic penlights. Constant use time of 30 minutes. One year shelf life warranty from date of purchase. Convenient clip-activated switch & imprinted medi...
Medicine Products: